Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis

被引：0
|
作者：
Calzetta, L. [1 ]
Cavalli, F. [2 ]
Chetta, A. [1 ]
Cazzola, M. [2 ]
Rogliani, P. [2 ]
机构：
[1] Univ Parma, Parma, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Asthma; Pharmacology; Treatments;
D O I：
10.1183/13993003.congress-2022.294
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
294
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A safety comparison of LABA plus LAMA vs LABA plus ICS combination therapy for COPD
    Matera, Maria Gabriella
    Calzetta, Luigino
    Puxeddu, Ermanno
    Rogliani, Paola
    Cazzola, Mario
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (05) : 509 - 517
  • [32] A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD
    Calzetta, Luigino
    Rogliani, Paola
    Matera, Maria Gabriella
    Cazzola, Mario
    CHEST, 2016, 149 (05) : 1181 - 1196
  • [33] Triple versus LAMA/LABA combination therapy for Japanese patients with COPD: A systematic review and meta-analysis
    Koarai, Akira
    Yamada, Mitsuhiro
    Ichikawa, Tomohiro
    Fujino, Naoya
    Kawayama, Tomotaka
    Sugiura, Hisatoshi
    RESPIRATORY INVESTIGATION, 2022, 60 (01) : 90 - 98
  • [34] Analysys Of The Clinical Feature Of COPD Patients With Triple Therapy(ics/laba/lama)
    Miyazaki, M.
    Nakamura, H.
    Sasaki, M.
    Haraguchi, M.
    Chubachi, S.
    Takahashi, S.
    Yoshida, S.
    Shirahata, T.
    Asano, K.
    Betsuyaku, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [35] LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
    Hizawa, Nobuyuki
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1093 - 1102
  • [36] Population Pharmacokinetic Analysis of Single Inhaler Triple Therapy (ICS/LAMA/LABA) Versus Dual Therapy (LAMA/LABA and ICS/LABA) in Patients with Symptomatic COPD: Combined Results from Three Phase III Trials
    Mehta, R.
    Farrell, C.
    Kilbride, S.
    Zhu, C.
    Brooks, J.
    Barnhart, F.
    Birk, R.
    Lipson, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [37] Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement
    Laitano, Rossella
    Calzetta, Luigino
    Matino, Matteo
    Pistocchini, Elena
    Rogliani, Paola
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (08) : 1071 - 1081
  • [38] LABA/LAMA combination, exercise and lung hyperinflation in COPD: a meta-analysis
    Cazzola, Mario
    Calzetta, Luigino
    Ora, Josuel
    Cavalli, Francesco
    O'Donnell, Denis E.
    Rogliani, Paola
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [39] The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients
    De Backer, Wilfried
    Vos, Wim
    Van Holsbeke, Cedric
    Vinchurkar, Samir
    Claes, Rita
    Hufkens, Annemie
    Parizel, Paul M.
    Bedert, Lieven
    De Backer, Jan
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (02) : 527 - 529
  • [40] Efficacy and safety profile of doxofylline in asthma: a meta-analysis
    Gao, Fa
    Li, Jian
    Hou, Yulong
    Sun, Shuxin
    Chen, Yiyuan
    Cao, Fang
    Xu, Hang
    Li, Jing
    JOURNAL OF ASTHMA, 2025, 62 (02) : 205 - 215
12345